Maverick Capital Ltd. Makes New Investment in UnitedHealth Group Incorporated $UNH

Key Points

• Maverick Capital Ltd. has acquired 146,918 shares of UnitedHealth Group, valued at approximately $76.9 million, making it the company's 24th largest holding.
• UnitedHealth Group's shares recently rose by 2.5%, bringing their market capitalization to $280.55 billion, despite reporting lower-than-expected earnings for the latest quarter.
• The company announced a quarterly dividend of $2.21 per share, with an annualized yield of 2.9%, to be paid on September 23rd.

Maverick Capital Ltd. purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 146,918 shares of the healthcare conglomerate's stock, valued at approximately $76,948,000. UnitedHealth Group comprises 1.4% of Maverick Capital Ltd.'s holdings, making the stock its 24th biggest holding.

A number of other institutional investors have also recently bought and sold shares of UNH. Bayforest Capital Ltd grew its position in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its position in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the first quarter valued at approximately $42,000. Copia Wealth Management acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $42,000. Finally, O Brien Wealth Partners LLC grew its position in shares of UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after purchasing an additional 37 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Up 2.5%

Shares of NYSE:UNH opened at $309.77 on Monday. The firm has a market cap of $280.55 billion, a P/E ratio of 13.42, a P/E/G ratio of 2.00 and a beta of 0.44. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The business has a fifty day simple moving average of $288.16 and a 200 day simple moving average of $379.63.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on UNH shares. HSBC reaffirmed a "reduce" rating and issued a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. JPMorgan Chase & Co. reduced their target price on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. Mizuho reduced their target price on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Finally, UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Fifteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $353.00.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.